The overexpression of miR-450a-2-3p suppressed the MAPK1 expression in CFs, thereby inhibiting the expression of α-SMA, COL1, and COL3 and preventing CF proliferation. This evidence concerns the gene ACTA1 and myalgic encephalomeyelitis/chronic fatigue syndrome.